Engager Cells For Immunotherapy

Patent No. EP2964675 (titled "Engager Cells For Immunotherapy") was filed by Baylor College OF Medicine on Mar 5, 2014. The application was issued on Jun 20, 2018.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
SCHLICH	Mar 19, 2019	SCHLICH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Feb 14, 2020
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Feb 14, 2020
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Feb 11, 2020
Termination of the opposition proceedings with revocation of patent
Oct 29, 2019
(Electronic) Receipt
Oct 29, 2019
Advice of delivery
Oct 29, 2019
Advice of delivery
Oct 29, 2019
Letter accompanying subsequently filed items
Oct 25, 2019
Acknowledgement of a document
Oct 25, 2019
Acknowledgement of a document
Oct 25, 2019
Decision of the Opposition Division and instruction
Oct 25, 2019
Decision revoking the European patent
Oct 25, 2019
Grounds for the decision (Annex) - opposition
Oct 25, 2019
Internal form - Opposition/addressees
Oct 25, 2019
Means of redress
Oct 25, 2019
Scanned annex to a communication - opposition procedure
Oct 18, 2019
Brief communication - Opposition proceedings
Oct 15, 2019
(Electronic) Receipt
Oct 15, 2019
Letter accompanying subsequently filed items
Oct 15, 2019
Letter regarding the opposition procedure (no time limit)
Apr 24, 2019
Brief communication - Opposition proceedings
Apr 16, 2019
(Electronic) Receipt
Apr 16, 2019
Letter accompanying subsequently filed items
Apr 16, 2019
Letter regarding the opposition procedure (no time limit)
Apr 16, 2019
Non-patent literature cited during the opposition procedure
Apr 16, 2019
Non-patent literature cited during the opposition procedure
Apr 5, 2019
Communication of a notice of opposition and request to file observations
Apr 5, 2019
Notice of further oppositions to opponent(s)
Apr 1, 2019
Request for the date of publication in citations
Mar 26, 2019
Communication of a notice of opposition - first information to patent proprietor
Mar 19, 2019
(Electronic) Receipt
Mar 19, 2019
Citation in opposition procedure
Mar 19, 2019
Citation in opposition procedure
Mar 19, 2019
Citation in opposition procedure
Mar 19, 2019
Citation in opposition procedure
Mar 19, 2019
Citation in opposition procedure
Mar 19, 2019
Citation in opposition procedure
Mar 19, 2019
Citation in opposition procedure
Mar 19, 2019
Non-patent literature cited during the opposition procedure
Mar 19, 2019
Non-patent literature cited during the opposition procedure
Mar 19, 2019
Non-patent literature cited during the opposition procedure
Mar 19, 2019
Non-patent literature cited during the opposition procedure
Mar 19, 2019
Non-patent literature cited during the opposition procedure
Mar 19, 2019
Non-patent literature cited during the opposition procedure
Mar 19, 2019
Non-patent literature cited during the opposition procedure
Mar 19, 2019
Notice of opposition
Mar 19, 2019
Notice of opposition
Mar 19, 2019
Patent document cited during the opposition procedure
Mar 19, 2019
Patent document cited during the opposition procedure
Mar 19, 2019
Patent document cited during the opposition procedure
Mar 19, 2019
Patent document cited during the opposition procedure
Jul 2, 2018
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
May 25, 2018
Decision to grant a European patent
May 10, 2018
(Electronic) Receipt
May 10, 2018
Filing of the translations of the claims
May 10, 2018
French translation of claims
May 10, 2018
German translation of the claims
May 10, 2018
Letter accompanying subsequently filed items
Jan 10, 2018
Bibliographic data of the European patent application
Jan 10, 2018
Communication about intention to grant a European patent
Jan 10, 2018
Intention to grant (signatures)
Jan 10, 2018
Text intended for grant (clean copy)
Jan 10, 2018
Text intended for grant (version for approval)
Nov 28, 2017
(Electronic) Receipt
Nov 28, 2017
Amended claims with annotations
Nov 28, 2017
Claims
Nov 28, 2017
Letter accompanying subsequently filed items
Nov 28, 2017
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Aug 11, 2017
Bibliographic data of the European patent application
Aug 11, 2017
Communication about intention to grant a European patent
Aug 11, 2017
Intention to grant (signatures)
Aug 11, 2017
Text intended for grant (clean copy)
Aug 11, 2017
Text intended for grant (sequence listing)
Aug 11, 2017
Text intended for grant (version for approval)
Jun 12, 2017
Communication of amended entries concerning the representative
Jun 7, 2017
Submission concerning change of applicant's representative
Jun 6, 2017
Submission concerning change of applicant's representative
Apr 26, 2017
(Electronic) Receipt
Apr 26, 2017
Amended claims with annotations
Apr 26, 2017
Amended description with annotations
Apr 26, 2017
Claims
Apr 26, 2017
Description
Apr 26, 2017
Letter accompanying subsequently filed items
Apr 26, 2017
Reply to communication from the Examining Division
Jan 11, 2017
Annex to the communication
Jan 11, 2017
Communication from the Examining Division
Dec 15, 2016
Examination started
Apr 22, 2016
(Electronic) Receipt
Apr 22, 2016
Amended claims filed after receipt of (European) search report
Apr 22, 2016
Amended claims with annotations
Apr 22, 2016
Amended description filed after receipt of (European) search report
Apr 22, 2016
Amended description with annotations
Apr 22, 2016
Amendments received before examination
Apr 22, 2016
Letter accompanying subsequently filed items
Dec 16, 2015
Notification on forthcoming publication of bibliographic data
Oct 13, 2015
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Oct 9, 2015
Communication to designated inventor
Oct 9, 2015
Communication to designated inventor
Oct 9, 2015
Communication to designated inventor
Oct 9, 2015
Communication to designated inventor
Oct 9, 2015
Communication to designated inventor
Sep 25, 2015
(Electronic) Receipt
Sep 25, 2015
Letter accompanying subsequently filed items
Sep 25, 2015
Letter concerning the inventor
Sep 23, 2015
(Electronic) Receipt
Sep 23, 2015
Amended claims filed after receipt of (European) search report
Sep 23, 2015
Amended claims with annotations
Sep 23, 2015
Amendments received before examination
Sep 23, 2015
Annex
Sep 23, 2015
Request for entry into the European phase
Sep 22, 2015
Copy of the international preliminary report on patentability
Jul 17, 2015
Information on entry into European phase
Oct 1, 2014
Priority document (electronically transmitted)
Oct 1, 2014
Priority document (electronically transmitted)
Oct 1, 2014
Priority document (electronically transmitted)
Oct 1, 2014
Priority document (electronically transmitted)
Sep 25, 2014
Converted Sequence Listing
Sep 12, 2014
Copy of the international search report
Sep 12, 2014
Published international application - A1
Jun 24, 2014
Written opinion of the ISA, boxes No. I to VIII
Jun 24, 2014
Written opinion of the ISA, cover sheet
Jun 24, 2014
Written opinion of the ISA, supplemental box
Jun 10, 2014
Annex
Jun 10, 2014
Annex
Mar 24, 2014
Abstract
Mar 24, 2014
Annex
Mar 24, 2014
Claims
Mar 24, 2014
Description
Mar 24, 2014
Drawings

EP2964675

BAYLOR COLLEGE OF MEDICINE

Application Number: EP14714473A
Filing Date: Mar 5, 2014
Status: Revoked; Feb 14, 2020
Publication Date: Jun 20, 2018
External Links: Slate, Register , Google Patents

IP Verse

Engager Cells For Immunotherapy

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2964675